Abstract:Background: End-stage kidney disease (ESKD) from lupus nephritis (LN) is a major cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Kidney biopsy is the gold standard for diagnosis and prognostication of LN. While interstitial fibrosis and tubular atrophy (IFTA) predict progression to ESKD, the National Institutes of Health (NIH) classification of interstitial inflammation in unscarred cortical parenchyma is not predictive of chronic kidney disease (CKD) progression. The objective of this study was to determine whether total cortical interstitial inflammation that accounts for inflammation in the entire cortical parenchyma could predict CKD progression in patients with LN. Early identification of at-risk patients may improve outcomes. Methods: This retrospective cohort study included 125 SLE patients with LN class III, IV, V or mixed (III/V, IV/V) on the index biopsy (2005-2018). Kidney biopsies were reviewed and assigned based on the 2018 NIH Activity Index (AI) and tubulointerstitial lesion categories. Total interstitial inflammation in the entire cortical parenchyma was graded as 0, 1, 2 or 3, corresponding to <10%, 10-25%, 26-50% and >50%, respectively, of the total cortical parenchyma containing an inflammatory infiltrate (similar to the definition used in the Banff total inflammation score). CKD progression was defined as an estimated glomerular filtration rate decrease of ≥30% within 5 years after the index biopsy. Kaplan-Meier survival curves and Cox proportional hazards models were performed to compare the two scoring systems, the total cortical intestinal inflammation score and the NIH interstitial inflammation score as predictors of CKD progression. Results: Of 125 patients, 46 experienced CKD progression; 21 of 46 subsequently developed ESKD, 28 (22.4%) had moderate-severe total cortical interstitial inflammation and 8 (6.4%) had moderate-severe NIH interstitial inflammation. There were no differences in baseline characteristics between progressors and nonprogressors. Total cortical interstitial inflammation was associated with CKD progression in time-dependent analyses [hazard ratio 2.45 (95% confidence interval 1.2-4.97)] adjusted for age at biopsy, race, sex, LN class and hypertensive vascular change on kidney biopsy. The NIH interstitial inflammation was not associated with CKD progression. Conclusions: In contrast to the current NIH interstitial inflammation classification, accounting for interstitial inflammation in the entire cortical parenchyma allows identification of patients at risk for CKD progression in LN.

Coexisting Tubulointerstitial Inflammation and Damage Is a Risk Factor for Chronic Kidney Disease in Patients With Lupus Nephritis

Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring

Total cortical interstitial inflammation predicts chronic kidney disease progression in patients with lupus nephritis

Interstitial fibrosis increases the risk of end-stage kidney disease in patients with lupus nephritis

The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis

One-year Renal Outcome in Lupus Nephritis Patients with Acute Kidney Injury: a Nomogram Model

Clinicopathological Characteristics and Prognosis of Lupus Nephritis Patients with Acute Kidney Injury

Association between tubulointerstitial CD8+T cells and renal prognosis in lupus nephritis

Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

Relationship Between Clinical Predictors and Tubulointerstitial Damage in Adult-Onset Primary Nephrotic Syndrome.

Tubular biomarkers and histology in lupus nephritis

Lipocalin-2 Exacerbates Lupus Nephritis by Promoting Th1 Cell Differentiation

Risk of chronic kidney disease in 260 patients with lupus nephritis—analysis of a nationwide multicentre cohort with up to 35 years of follow-up

Epidemiology and Risk Factors for Chronic Kidney Disease in Chinese Patients with Biopsy‐proven Lupus Nephritis

Inflammation in Areas of Fibrosis Precedes Loss of Kidney Function in Lupus Nephritis

Tubulointerstitial Lesions of Patients with Lupus Nephritis Classified by the 2003 International Society of Nephrology and Renal Pathology Society System.

Characteristics and Renal Survival of Patients with Lupus Nephritis with Glomerular Immunoglobulin G4 Deposition: a Single-Centre Retrospective Analysis.

Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study

Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage

Lupus nephritis-related chronic kidney disease